Amana Mutual Funds Trust recently released its Q1 2020 Investor Letter, a copy of which you can download here.
Keep Reading →
June 17 - Hedge Fund Investor Letters, News
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the...
Keep Reading →
June 15 - Hedge Funds, News
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
Keep Reading →
March 12 - Hedge Funds, News
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
December 8 - Hedge Funds, News
Is Novo Nordisk A/S (NYSE:NVO) a good bet right now? We like to analyze hedge fund sentiment before conducting days of in-depth research.
Keep Reading →
October 9 - Hedge Funds, News
It was a rough fourth quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 4.8% during 2018 and ...
Keep Reading →
March 26 - Hedge Funds, News
Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap...
Keep Reading →
December 19 - Hedge Funds, News
Fisher Investments was founded in 1979 by billionaire Ken Fisher.
Keep Reading →
November 13 - Dividend Stocks, Hedge Funds, News
The 30 most obese countries in the world in 2018 represent a huge (pun intended) market opportunity for weight loss drugmakers.
Keep Reading →
March 22 - News
The 10 least obese countries in the world are mostly from Asia and Africa.
Keep Reading →
March 26 - Lists, News
Global Blood Therapeutics Inc (NASDAQ:GBT) is spiking towards the end of the week on the suggestion that it might be an acquisition target for a big pharma name.
Keep Reading →
March 10 - News, Stock Analysis
The problem of obesity is a modern one, with large sections of the global population becoming overweight late in the 20th century and into the 21st, and the prevalence is especially...
Keep Reading →
January 17 - Lists, News
Novo Nordisk A/S (ADR) (NYSE:NVO) has been sued by Sanofi SA (ADR) (NYSE:SNY) for making false claims.
Keep Reading →
December 28 - News, Stock Analysis
Which are the largest hedge funds in the world? Most investors see hedge fund size as an indication of investment success.
Keep Reading →
December 8 - Hedge Funds, News
After several tireless days we have finished crunching the numbers from the more than 700 13F filings issued by the successful hedge funds and other investment firms that we track...
Keep Reading →
December 5 - Hedge Funds, News
The US Food and Drug Administration (FDA) has recently approved the Soliqua 100/33 (insulin glargine and lixisenatide injection) of Sanofi SA (ADR) (NYSE:SNY) and the Xultophy...
Keep Reading →
November 23 - News, Stock Analysis
These 10 most successful investors in the world don’t have much in common aside from their obscene net worths.
Keep Reading →
November 2 - ETF Trading, Hedge Funds, Lists, News
Novo Nordisk A/S (ADR) (NYSE:NVO) incoming President and CEO Lars Fruergaard Jørgensen is slated to start his leadership roles in the New Year.
Keep Reading →
November 1 - News
It is hard to be the CEO of a company these days given the increasing political uncertainty and slow growth being faced by major developed economies.
Keep Reading →
October 31 - Hedge Funds, News
The prominence of quantitative hedge funds in the alternative asset management space has increased exponentially since the turn of the century, with several of them now considered...
Keep Reading →
October 22 - Hedge Funds, News, Quantitative Investing
In the past few days, I have noticed that a couple of dividend growth stocks have been selling at lower prices than before.
Keep Reading →
October 12 - Dividend Stocks, News, Stock Analysis
Markets shrugged off the negative trend and are trading well in the green today amid news that World Trade Organization’s has slashed its world trade forecast to the lowest...
Keep Reading →
September 27 - Hedge Funds, News
Update: Several hours after the initial publication of this report on September 2, Novo Nordisk announced that the FDA has extended the regulatory review for IDeglira, with...
Keep Reading →
September 6 - News, Stock Analysis
In this article we'll take a look at why VeriFone Systems Inc (NYSE:PAY), Dynavax Technologies Corporation (NASDAQ:DVAX), Gilead Sciences, Inc.
Keep Reading →
September 5 - Market Movers, News
The problem with being at the top of one of the largest healthcare market niches in the world is extremely heightened expectations.
Keep Reading →
August 9 - News, Stock Analysis
In part I of our comprehensive report on the type II diabetes market, we broke down the top 4 best selling diabetes drugs, their prospects and the companies behind them.
Keep Reading →
June 27 - News, Stock Analysis
At the turn of the millennium, the population of the United States clocked in at 282.2 million.
Keep Reading →
June 22 - News, Stock Analysis
Founded in 1982 by James ‘Jim’ Simons, Renaissance Technologies employs quantitative models based on mathematical and statistical analysis to make its stock selections and...
Keep Reading →
May 18 - Hedge Fund Analysis, Hedge Funds, News
Is Novo Nordisk A/S (ADR) (NYSE:NVO) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research.
Keep Reading →
November 30 - Hedge Funds, News
Well-known hedge fund Renaissance Technologies LLC needs little or no introduction at all.
Keep Reading →
November 14 - Hedge Fund Analysis, Hedge Funds, News
Arrowstreet Capital is a Boston, Massachusetts-based quantitative hedge fund founded by Peter Rathjens, Bruce Clarke and John Campbell in 1999.
Keep Reading →
November 11 - Hedge Fund Analysis, Hedge Funds, News
At the beginning of September, when the U.S stock markets were in turmoil, Ken Fisher of Fisher Asset Management asserted that the August correction would be “over just as fast...
Keep Reading →
November 3 - Hedge Fund Analysis, Hedge Funds, News
On October 15, Emisphere Technologies Inc.
Keep Reading →
October 16 - Hedge Funds, Market Movers, News
Renaissance Technologies, led by Jim Simons, disclosed a total of 3,196 positions in its latest 13F filing for the reporting period of June 30.
Keep Reading →
October 8 - Hedge Fund Analysis, Hedge Funds, News
Novo Nordisk A/S (ADR) (NYSE:NVO) and Sanofi SA (ADR) (NYSE:SNY) are two healthcare companies that recently received product approval in the US and Europe, respectively, but both...
Keep Reading →
September 28 - Market Movers, News
Renaissance Technologies, founded by billionaire Jim Simons, has filed its latest 13F with the U.S.
Keep Reading →
May 17 - Hedge Funds, News
Tom Gayner’s Markel Gayner Asset Management, the investment division of financial holding company Markel Corporation (NYSE:MKL), has filed its latest 13F with the Securities...
Keep Reading →
May 14 - Hedge Funds, News
As we are entering into the second quarter of 2015, it's time to take a brief look back and see how the market performed during the first three months of the year, and most importantly...
Keep Reading →
April 1 - Hedge Funds, News, Tech
The quantitative hedge fund Renaissance Technologies, formerly managed by billionaire Jim Simons, has been so successful that it has been partly responsible for prompting other...
Keep Reading →
March 27 - Hedge Funds, News
Another major hedge fund that recently disclosed its long equity positions for the second quarter of 2014 is Jim Simons’ Renaissance Technologies, one of the best performing...
Keep Reading →
August 14 - Hedge Funds
In the latest 13F, Renaissance Technologies, previously managed by Jim Simons, revealed its holding for the fourth quarter of 2013.
Keep Reading →
February 14 - Hedge Funds, News
This is close to the market cap that Bank of America's Steve Byrne thinks MannKind Corporation (NASDAQ:MNKD) is worth.
Keep Reading →
September 17 - News
Dividend investors would be wise to focus not just on a stock's current yield, but also on the long-term growth potential of its dividends.
Keep Reading →
September 16 - Dividend Stocks, News
In pharmacology, we don't only have to consider the actions of the drug on the body.
Keep Reading →
September 12 - News
Express Scripts Holding Company (NASDAQ:ESRX) -- the largest pharmacy benefit manager, or PBM, in America -- is also one of the most important companies in the health care ...
Keep Reading →
September 11 - News
In the 21st century investor’s toolkit, there are a multitude of metrics investors can use to track Mr. Market.
Keep Reading →
September 5 - News
The drug more closely mimics how the body secretes insulin after a meal to lower blood sugar, doing its job and leaving the bloodstream quickly.
Keep Reading →
September 2 - News
The idea inspired me to issue my own questions about the company, using the questions as a crutch to explain my position.
Keep Reading →
August 28 - News
In the eyes of many of your fellow readers, hedge funds are seen as useless, old financial vehicles of an era lost to time.
Keep Reading →
August 26 - News
The orthopedic implants market is a growing segment with increasing demand for extremities, spine, and orthobiologics.
Keep Reading →
August 22 - News